The University of Cincinnati and Physicians Education Resources®, LLC (PER®), are both accredited by the ACCME to provide continuing medical education for physicians, and have collaborated to design and execute these live and enduring educational activities.
For accreditation purposes, The University of Cincinnati is responsible for certification and documentation of attendance for these activities.
The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this enduring material for a maximum 1.5 AMA PRA Category 1 Credits™.
Acknowledgment of Commercial Support
This activity is supported by independent educational grants from AstraZeneca; Genomic Health, Inc.; Merck & Co., Inc; and Sanofi Genzyme.
CFS: Medical Crossfire®: Exploring the Latest Advancements in Prostate Cancer Care
10:10 am - 11:40 am
(Attendee registration: 9:40 am - 10:10 am)
New York Marriott Marquis
New York, NY 10036
In the past decade, the treatment armamentarium for advanced/metastatic hormone-naïve and castration-resistant prostate cancer (CRPC) has expanded dramatically, providing more choices and greater potential to improve clinical outcomes, but also increasing the complexity of decision making in the clinic. The available agents have different mechanisms of action, different safety profiles, and provide different clinical outcomes. In this Medical Crossfire® activity, the expert panel will discuss the latest data regarding current and emerging therapeutic strategies for the management of prostate cancer across lines of care. A case-based, lively discussion format will help place new developments into clinical context to help you optimize care for your patients with prostate cancer.
Benefits of Attending
- Hear the latest updates on emerging strategies for the care of your patients with prostate cancer.
- Contextualize emerging data through challenging case-based scenarios across lines of care in prostate cancer.
- Benefit from discussion of how the experts best apply advances in the field of prostate cancer to manage their patients.
Acknowledgement of Commercial Support
This activity is supported by independent educational grants from AstraZeneca; Genomic Health, Inc.; Merck & Co., Inc.; and Sanofi Genzyme.
This educational activity is intended for oncologists and other healthcare professionals interested in the treatment of prostate cancer.
Upon completion of this activity, participants will be able to:
- Describe emerging therapeutic options in prostate cancer across multiple patient populations and lines of care.
- Integrate novel clinical evidence into clinical practice to optimize the clinical outcome of prostate cancer patients.
- Optimize treatment sequences using novel agents for the treatment of prostate cancer patients.
- Define strategies to proactively identify and mitigate adverse events associated with different prostate cancer treatment options.
University of Virginia Cancer Center
University of Virginia
Registration2 Ways to Register
- Online: Click here.
- Phone: Please call +1-(888)-949-0045 or +1-(609)-378-3701.
2 Clarke Drive
Cranbury, NJ 08512
Registration Fee - Free
For registration assistance, please email email@example.com, or call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.
Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.
You must be logged in to PER to register for this meeting
Or Register for PER now